DURHAM, NC--(Marketwired - March 11, 2014) - DPx Holdings B.V. (DPx), privately owned by JLL Partners and Royal DSM, today launched as a leading global contract development and manufacturing ...
Durham, N.C. and St. Louis — (August 27, 2014)—DPx Holdings B.V., privately owned by JLL Partners and Royal DSM, is pleased to announce that it has reached a definitive agreement to acquire all shares ...
Based on promising results, the biotech IMV has moved into phase 2b trials with a cancer vaccine composed of survivin epitopes that uses the company’s proprietary delivery system to elicit persistent ...
Hosted on MSN
BioVaxys sharpens DPX vaccine strategy with new leadership and positive breast cancer data
BioVaxys Technology ( (TSE:BIOV)) just unveiled an announcement. BioVaxys’ 2025 corporate review highlights the integration of the DPX platform into its operations and a strategic shift toward organic ...
Once you start toting a knife in your EDC, you’ll wonder how you ever lived without it. Cutting, prying, and oh-so-important meat-slicing — you’ve never had it so good. There are plenty of fantastic ...
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against ...
The novel lipid-in-oil delivery platform showed positive results across multiple disease states. BioVaxys Technology Corp announced key findings from its research into the use of novel lipid-in-oil ...
$2.65 billion transaction combines the capabilities and expertise of Patheon and DSM Pharmaceutical Products to create industry powerhouse Durham, N.C. — (March 11, 2014)—DPx Holdings B.V. (DPx), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results